HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jann N Sarkaria Selected Research

methanesulfonyl isopropyl lactate

1/2021Peak learning of mass spectrometry imaging data using artificial neural networks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jann N Sarkaria Research Topics

Disease

132Neoplasms (Cancer)
12/2022 - 12/2002
116Glioblastoma (Glioblastoma Multiforme)
12/2022 - 12/2002
39Brain Neoplasms (Brain Tumor)
08/2022 - 01/2003
39Glioma (Gliomas)
04/2022 - 12/2002
11Breast Neoplasms (Breast Cancer)
01/2022 - 10/2012
9Melanoma (Melanoma, Malignant)
04/2022 - 08/2014
7Astrocytoma (Pilocytic Astrocytoma)
07/2019 - 12/2008
6Ataxia Telangiectasia (Louis Bar Syndrome)
12/2021 - 01/2002
5Carcinogenesis
06/2015 - 12/2004
4Neoplasm Metastasis (Metastasis)
04/2022 - 10/2010
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 08/2007
3Hypoxia (Hypoxemia)
01/2022 - 01/2018
2Colorectal Neoplasms (Colorectal Cancer)
04/2022 - 01/2021
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 04/2015
2Lung Neoplasms (Lung Cancer)
01/2021 - 08/2007
2Multiple Myeloma
01/2021 - 04/2014
2Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 10/2018
2Oligodendroglioma
07/2019 - 07/2019
2Infections
10/2018 - 11/2010
2Fatigue
01/2018 - 10/2011
2Disease Progression
01/2018 - 09/2015

Drug/Important Bio-Agent (IBA)

45Temozolomide (Temodar)FDA LinkGeneric
04/2022 - 09/2007
35Pharmaceutical PreparationsIBA
04/2022 - 12/2002
27Proteins (Proteins, Gene)FDA Link
04/2022 - 12/2008
17Phosphotransferases (Kinase)IBA
04/2022 - 01/2002
16ErbB Receptors (EGF Receptor)IBA
12/2021 - 01/2003
11epidermal growth factor receptor VIIIIBA
01/2021 - 03/2007
10Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2019 - 10/2012
9DNA (Deoxyribonucleic Acid)IBA
10/2021 - 05/2008
8TOR Serine-Threonine KinasesIBA
01/2018 - 01/2002
7Erlotinib Hydrochloride (CP 358,774)FDA Link
10/2019 - 03/2007
6Biomarkers (Surrogate Marker)IBA
11/2021 - 04/2006
6Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2018 - 02/2009
5RNA (Ribonucleic Acid)IBA
12/2021 - 01/2018
5Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020 - 08/2014
5Alkylating AgentsIBA
01/2019 - 05/2008
5Mitogen-Activated Protein KinasesIBA
01/2019 - 08/2014
4HydrogelsIBA
01/2022 - 11/2017
4DNA-Activated Protein KinaseIBA
01/2022 - 02/2011
4Hyaluronic Acid (Hyaluronan)IBA
01/2022 - 11/2017
4Radiation-Sensitizing AgentsIBA
01/2022 - 09/2009
4EnzymesIBA
10/2021 - 03/2017
4Tyrosine (L-Tyrosine)FDA Link
01/2021 - 12/2011
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021 - 04/2005
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 01/2013
4Dasatinib (BMS 354825)FDA Link
10/2020 - 10/2012
4EverolimusFDA Link
10/2020 - 06/2008
4Sirolimus (Rapamycin)FDA Link
01/2018 - 12/2002
4Amino AcidsFDA Link
01/2018 - 03/2007
4Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA
03/2016 - 12/2011
3LuciferasesIBA
01/2022 - 09/2007
3GelatinIBA
01/2022 - 10/2019
3Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2022 - 01/2018
3Biological ProductsIBA
01/2021 - 12/2010
3Bevacizumab (Avastin)FDA Link
11/2020 - 01/2013
3MethyltransferasesIBA
01/2020 - 09/2009
3Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2019 - 06/2008
3Tyrosine Kinase InhibitorsIBA
10/2019 - 11/2017
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2019 - 12/2008
3Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2018 - 02/2016
3temsirolimusFDA Link
01/2018 - 11/2010
3palbociclibIBA
11/2016 - 07/2012
3veliparibIBA
05/2016 - 02/2009
3Small Interfering RNA (siRNA)IBA
03/2016 - 02/2012
3src-Family KinasesIBA
11/2015 - 02/2012
2dabrafenibIBA
04/2022 - 08/2014
2Firefly LuciferasesIBA
01/2022 - 01/2009
2Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2013
2TransposasesIBA
01/2022 - 10/2021
2salicylhydroxamic acid (SHAM)IBA
01/2022 - 01/2020
2berzosertibIBA
12/2021 - 11/2018
2Cisplatin (Platino)FDA LinkGeneric
12/2021 - 08/2007
2Protein Kinases (Protein Kinase)IBA
11/2021 - 10/2005
2LigandsIBA
01/2021 - 04/2016
2Neuropilin-1IBA
12/2020 - 11/2020
2Hormones (Hormone)IBA
10/2020 - 03/2017
2SteroidsIBA
10/2020 - 01/2016
2PT2385IBA
01/2020 - 01/2018
2Protein Isoforms (Isoforms)IBA
12/2019 - 01/2016
2SAR405838IBA
12/2019 - 01/2018
2ParaffinIBA
11/2019 - 10/2017
2Formaldehyde (Formol)FDA Link
11/2019 - 10/2017
2TensinsIBA
10/2019 - 12/2008
2Imatinib Mesylate (Gleevec)FDA Link
07/2019 - 07/2019
2Thromboplastin (Tissue Factor)IBA
01/2019 - 04/2015
2vandetanib (ZD6474)IBA
01/2019 - 04/2010
2Gefitinib (Iressa)FDA Link
01/2019 - 04/2016
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
11/2018 - 11/2017
2Histones (Histone)IBA
01/2018 - 08/2012
2ponatinibIBA
01/2018 - 11/2017
2Insulin-Like PeptidesIBA
01/2018 - 01/2016
2Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2018 - 04/2010
2GadoliniumIBA
01/2018 - 01/2015
2Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
12/2017 - 12/2007

Therapy/Procedure

68Therapeutics
04/2022 - 01/2003
23Radiotherapy
01/2022 - 12/2002
23Drug Therapy (Chemotherapy)
01/2022 - 01/2003
3Immunotherapy
01/2021 - 09/2017
2Chemoradiotherapy
01/2020 - 11/2010
2Lasers (Laser)
01/2019 - 12/2015